February 9, 2018
US Bioservices now dispenses BIKTARVY
The U.S. Food and Drug Administration has approved BIKTARVY (bictegravir, emtricitabine, tenofovir alafenamide) for the treatment of adults with HIV-1 infection.
The U.S. Food and Drug Administration has approved BIKTARVY (bictegravir, emtricitabine, tenofovir alafenamide) for the treatment of adults with HIV-1 infection.